Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Clinical trial NCT06739928 · RECRUITING

Trial details

NCT number: NCT06739928
Sponsor: Guangzhou Institute of Respiratory Disease
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage

Start date: 2025-01-01
Primary completion: 2026-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.